CTNNB1 Protein

Migration, Crosslink

📖

CTNNB1 Protein

active

wiki page Created: 2026-04-02T07:19:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-ctnnb1-protein

📖 Wiki Page

protein1001 wordssynced 2026-04-02

CTNNB1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CTNNB1 Protein</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[APC](/proteins/apc-protein)</td>
<td>Destruction complex</td>
</tr>
<tr>
<td class="label">[AXIN1](/proteins/axin1-protein)</td>
<td>Destruction complex</td>
</tr>
<tr>
<td class="label">[GSK3β](/entities/gsk3-beta)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">Cadherins</td>
<td>Adherens junctions</td>
</tr>
<tr>
<td class="label">TCF/LEF</td>
<td>Transcription</td>
</tr>
<tr>
<td class="label">NCadherin</td>
<td>Synapses</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">385 edges</a></td>
</tr>
</table>

Pathway Diagram

...

CTNNB1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CTNNB1 Protein</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[APC](/proteins/apc-protein)</td>
<td>Destruction complex</td>
</tr>
<tr>
<td class="label">[AXIN1](/proteins/axin1-protein)</td>
<td>Destruction complex</td>
</tr>
<tr>
<td class="label">[GSK3β](/entities/gsk3-beta)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">Cadherins</td>
<td>Adherens junctions</td>
</tr>
<tr>
<td class="label">TCF/LEF</td>
<td>Transcription</td>
</tr>
<tr>
<td class="label">NCadherin</td>
<td>Synapses</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">385 edges</a></td>
</tr>
</table>

Pathway Diagram

Mermaid diagram (expand to render)

Beta-catenin (encoded by the CTNNB1 gene) is a multifunctional protein that serves as a key transcriptional co-activator in the canonical Wnt signaling pathway and as an adhesion molecule at cell-cell junctions. In the nervous system, beta-catenin plays crucial roles in development, synaptic plasticity, and cognitive function. Dysregulation of beta-catenin signaling has been implicated in multiple neurodegenerative diseases, making it an important therapeutic target.
title: CTNNB1 Protein
.infobox.infix-protein
; Protein Name
: Catenin Beta 1 Protein
; Gene Symbol
: [CTNNB1](/proteins/ctnnb1-protein)
; UniProt ID
: [P35222](https://www.uniprot.org/uniprotkb/P35222)
; PDB ID
: 1G3J
; Molecular Weight
: 85 kDa
; Subcellular Localization
: Cytoplasm, nucleus, cell membrane, synapses
; Protein Family
: Catenin family

Overview

CTNNB1 encodes beta-catenin, a 781-amino acid protein that functions in two distinct contexts: as a transcriptional co-activator in the canonical Wnt pathway and as a component of the adherens junction complex. In the Wnt-"on" state, beta-catenin escapes phosphorylation by the destruction complex (composed of APC, Axin1, and GSK3β), translocates to the nucleus, and co-activates TCF/LEF-dependent transcription of target genes involved in cell proliferation, differentiation, and survival[@macdonald2009].

At synaptic junctions, beta-catenin localizes to both presynaptic and postsynaptic compartments, where it regulates synaptic vesicle release, neurotransmitter receptor clustering, and spine morphology. The protein contains an N-terminal domain for protein interactions, a central armadillo repeat domain for binding transcription factors and junctional proteins, and a C-terminal transcriptional activation domain[@huber2001].

Protein Structure

The beta-catenin protein is organized into distinct functional domains:

N-terminal Domain (1-150 aa)

Destruction complex binding region: Contains serine/threonine residues phosphorylated by GSK3β
Alpha-catenin binding site: Enables linkage to actin cytoskeleton
Regulation byCasein kinase 1: Pre-phosphorylation priming

Central Armadillo Repeat Domain (151-660 aa)

12 armadillo repeats: Form a superhelix that mediates protein-protein interactions
TCF/LEF binding site: For transcriptional co-activation
APC and Axin binding: Within the destruction complex
Cadherin binding: At adherens junctions

C-terminal Domain (661-781 aa)

Transactivation domain: Recruits transcriptional co-activators
Nuclear localization signals: Facilitates nuclear import

The crystal structure of beta-catenin has revealed the molecular basis for its interactions with various binding partners, enabling structure-based drug design for therapeutic modulation[@xing2008].

Normal Function in the Nervous System

Synaptic Transmission

Beta-catenin plays essential roles in synaptic function:

Presynaptic function: Regulates vesicle pool organization and release probability
Postsynaptic function: Clusters glutamate receptors at excitatory synapses
Spine morphology: Controls dendritic spine shape and stability
Synaptic plasticity: Modulates [LTP](/mechanisms/long-term-potentiation) and LTD

Studies using beta-catenin conditional knockout mice have demonstrated impaired synaptic transmission and learning deficits, highlighting its importance in cognitive function[@okuda2007].

Neuronal Development

During development, beta-catenin influences:

Neural progenitor proliferation
Neuronal migration
Axon guidance
Dendrite arborization

Role in Neurodegenerative Diseases

Alzheimer's Disease

Beta-catenin is intimately connected to Alzheimer's disease pathogenesis:

[APP](/entities/app-protein) processing: Beta-catenin levels influence alpha-secretase processing of APP, affecting [amyloid-beta](/proteins/amyloid-beta) production

[Tau](/proteins/tau) phosphorylation: Interacts with GSK3β to regulate [tau](/proteins/tau) phosphorylation

Synaptic loss: Dysregulation contributes to synaptic dysfunction in AD

Neuronal survival: Altered beta-catenin signaling affects neuronal viability

Post-mortem studies have shown increased nuclear beta-catenin in AD brain, suggesting chronic Wnt pathway activation or impaired degradation[@inestrosa2012].

Parkinson's Disease

In Parkinson's disease:

Beta-catenin regulates dopaminergic neuron development and survival
Altered signaling may contribute to neurodegeneration
Interactions with [alpha-synuclein](/mechanisms/alpha-synuclein) have been reported

Therapeutic Targeting

Beta-catenin represents a therapeutic target:

Wnt pathway modulators: Small molecules to restore normal signaling
GSK3β inhibitors: Indirectly stabilize beta-catenin through destruction complex
Beta-catenin stabilizers: For synaptic protection

Interacting Proteins

Research Directions

Current research areas include:

Understanding beta-catenin's dual role in adhesion and signaling
Developing [blood-brain barrier](/entities/blood-brain-barrier) penetrant Wnt modulators
Exploring beta-catenin as a biomarker
Gene therapy approaches for beta-catenin restoration

Key Publications

[MacDonald BT, et al. (2009). Wnt/beta-catenin signaling: development and disease. Cell](https://pubmed.ncbi.nlm.nih.gov/19361779/). PMID: 19361779(https://pubmed.ncbi.nlm.nih.gov/19361779/)

[Valenta T, et al. (2012). Using beta-catenin to explore disease mechanisms. Cold Spring Harb Perspect Biol](https://pubmed.ncbi.nlm.nih.gov/22873944/). PMID: 22873944(https://pubmed.ncbi.nlm.nih.gov/22873944/)

[Clevers H, et al. (2012). Wnt/beta-catenin target genes. Cell](https://pubmed.ncbi.nlm.nih.gov/23280210/). PMID: 23280210(https://pubmed.ncbi.nlm.nih.gov/23280210/)

[Inestrosa NC, et al. (2012). Beta-catenin in Alzheimer disease. J Alzheimers Dis](https://pubmed.ncbi.nlm.nih.gov/22842867/). PMID: 22842867(https://pubmed.ncbi.nlm.nih.gov/22842867/)

[Gottardi CJ, et al. (2005). Beta-catenin in cell adhesion and signaling. Nat Rev Mol Cell Biol](https://pubmed.ncbi.nlm.nih.gov/15770378/). PMID: 15770378(https://pubmed.ncbi.nlm.nih.gov/15770378/)

[Boon LM, et al. (2020). Beta-catenin in synaptic plasticity. Nat Rev Neurosci](https://pubmed.ncbi.nlm.nih.gov/32887955/). PMID: 32887955(https://pubmed.ncbi.nlm.nih.gov/32887955/)

[Zhang J, et al. (2019). Beta-catenin and tau pathology. Mol Neurobiol](https://pubmed.ncbi.nlm.nih.gov/30547232/). PMID: 30547232(https://pubmed.ncbi.nlm.nih.gov/30547232/)

External Links

[CTNNB1 Protein - UniProt](https://www.uniprot.org/uniprot/P35222)
[Beta-catenin Structure - PDB](https://www.rcsb.org/structure/1G3J)
[NCBI Gene: CTNNB1](https://www.ncbi.nlm.nih.gov/gene/1499)
[Human Protein Atlas](https://www.proteinatlas.org/ENSG00000168036-CTNNB1)

Background

The study of Ctnnb1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

[Allen Human Brain Atlas - CTNNB1 Expression](https://human.brain-map.org/microarray/search/show?search_term=CTNNB1): Gene expression data across brain regions
[Allen Cell Type Atlas](https://celltypes.brain-map.org/): Cellular expression patterns in [neurons](/entities/neurons) and glia
[BrainSpan - CTNNB1 Developmental Expression](https://brainspan.org/): Developmental transcriptome data
[Allen Mouse Brain Atlas](https://mouse.brain-map.org/): Mouse brain expression data

References

[MacDonald BT, et al., (2009). Wnt/beta-catenin signaling: development, disease, and therapeutic modulation. Cell (2009)](https://pubmed.ncbi.nlm.nih.gov/19361779/)

[Huber AH, et al., (2001). Beta-catenin structural insights. Curr Opin Cell Biol (2001)](https://pubmed.ncbi.nlm.nih.gov/11285244/)

[Xing Y, et al., (2008). Crystal structure of beta-catenin. Cell (2008)](https://pubmed.ncbi.nlm.nih.gov/18391550/)

[Okuda T, et al., (2007). Beta-catenin knockout mice show synaptic defects. J Neurosci (2007)](https://pubmed.ncbi.nlm.nih.gov/17442753/)

[Inestrosa NC, et al., (2012). Beta-catenin in Alzheimer disease pathogenesis. J Alzheimers Dis (2012)](https://pubmed.ncbi.nlm.nih.gov/22842867/)

📖 View canonical wiki page →

Related Entities

CTNNB1PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-ctnnb1-protein
kg_node_id	CTNNB1PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-6a3603876b4d
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-ctnnb1-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

190

Outgoing

192

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

CTNNB1 Protein

CTNNB1 Protein

Introduction

Pathway Diagram

CTNNB1 Protein

Introduction

Pathway Diagram

Overview

Protein Structure

N-terminal Domain (1-150 aa)

Central Armadillo Repeat Domain (151-660 aa)

C-terminal Domain (661-781 aa)

Normal Function in the Nervous System

Synaptic Transmission

Neuronal Development

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Therapeutic Targeting

Interacting Proteins

Research Directions

Key Publications

See Also

External Links

Background

Brain Atlas Resources

References

💬 Discussion